- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07520227
Comparative Evaluation of 3D-printed (PEEK) Plates Versus Titanium 3D Plate for Fracture Fixation at the Mandibular Angle
April 7, 2026 updated by: Osama Abdelaziz Abdelreheem Abdelhaleem, Cairo University
Comparative Evaluation of 3D-printed Polyetheretherketone (PEEK) Plates Versus Titanium 3D Plate for Fracture Fixation at the Mandibular Angle
Is patient specific customized computer assisted 3D PEEK plates more superior to 3D titanium plate in fixation of mandibular angle fractures?
Study Overview
Status
Completed
Conditions
Detailed Description
Open Reduction Internal fixation (ORIF) of mandibular angle fractures using titanium plating systems had several drawbacks including sepsis with subsequent wound dehiscence and the need for 2nd surgery which is attributed to bone loss as a result of the elevated modulus of elasticity of titanium hardware.
Accordingly, attempts were made to overcome problems encountered with the titanium plating system.
In this study, custom made PEEK 3D plates will be used in ORIF of mandibular angle fractures.
The main beneficial property of PEEK material is its lower modulus of elasticity that is close to that of living bone with subsequent elimination of the problem of stress shielding phenomenon encountered with titanium plating system.
PEEK material has other advantages including biocompatibility, mechanical strength, durability, resistance to high degree of temperature without dimensional alteration.
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Osama Abdelaziz Abdelreheem
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with mandibular angle fractures indicated for open reduction and internal fixation (ORIF).
- Patients aged 18 years and above.
- Both male and female patients.
- Patients medically fit for surgery under general anesthesia.
- Patients providing informed consent.
Exclusion Criteria:
- Patients with pathological fractures.
- Patients with comminuted fractures not suitable for fixation with plates.
- Patients with systemic conditions affecting bone healing (e.g., uncontrolled diabetes, osteoporosis).
- Patients with a history of previous mandibular surgery in the same region.
- Patients who are unable or unwilling to comply with follow-up.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Computer-assisted PEEK custom made 3D plates
Patients were treated using computer-assisted patient-specific PEEK plates manufactured by CAD/CAM technology and fixed using titanium screws.
|
Patient-specific PEEK plates manufactured using CAD/CAM technology and fixed using titanium screws.
|
|
Active Comparator: 3D titanium plates on the mandibular angle will be fixed using titanium screws
Patients were treated using conventional 3D titanium plates fixed with titanium screws after reduction of the fracture.
|
Conventional 3D titanium plates used for fixation of mandibular angle fractures with titanium screws.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative occlusion stability(binary: yes/no)
Time Frame: 1 week, 1 month, and 6 months postoperatively
|
Occlusal stability was recorded as stable or unstable.
Occlusal stability was assessed clinically by evaluating the intercuspation between maxillary and mandibular teeth.
Proper occlusion was defined as normal intercuspation without premature contacts or occlusal discrepancies.
Any deviation, including open bite or malocclusion, was recorded during follow-up.
|
1 week, 1 month, and 6 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Condylar seating (binary: yes/no)
Time Frame: 1 week, 1 month, and 6 months postoperatively
|
Condylar seating was assessed radiographically using standardized panoramic radiographs.
The position of the mandibular condyle within the glenoid fossa was evaluated.
Proper condylar seating was defined as a normal anatomical position without displacement.
Any deviation from the normal position was recorded as improper.
|
1 week, 1 month, and 6 months postoperatively
|
|
Postoperative infection (binary: yes/no)
Time Frame: 1 week, 1 month, and 6 months postoperatively
|
Postoperative infection was recorded as present or absent.
|
1 week, 1 month, and 6 months postoperatively
|
|
Wound dehiscence (binary: yes/no)
Time Frame: 1 week, 1 month, and 6 months postoperatively
|
Wound dehiscence was recorded as present or absent.
|
1 week, 1 month, and 6 months postoperatively
|
|
Need for second surgical intervention ( binary: yes/no)
Time Frame: 1 week, 1 month, and 6 months postoperatively
|
Need for second surgery was recorded as yes or no.
|
1 week, 1 month, and 6 months postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Hamida Refaae, PhD, Cairo University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Maurice V, Russet F, Scocco P, McNicholas F, Santosh P, Singh SP, Street C, Purper-Ouakil D. Transition from child and adolescent mental health care to adult services for young people with Attention-Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD) in Europe: Barriers and recommendations. Encephale. 2022 Oct;48(5):555-559. doi: 10.1016/j.encep.2022.01.012. Epub 2022 Jun 18.
- Fun WH, Tan EH, Sararaks S, Md Sharif S, Ab Rahim I, Jawahir S, Eow VHY, Sibert RMY, Fadzil MM, Mahmud SH. Implications of Dual Practice on Cataract Surgery Waiting Time and Rescheduling: The Case of Malaysia. Healthcare (Basel). 2021 May 31;9(6):653. doi: 10.3390/healthcare9060653.
- Amir O, Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Ash N, Alroy-Preis S, Huppert A, Milo R. Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine. Nat Commun. 2022 Apr 13;13(1):1971. doi: 10.1038/s41467-022-29578-w.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 20, 2023
Primary Completion (Actual)
October 30, 2024
Study Completion (Actual)
December 1, 2024
Study Registration Dates
First Submitted
March 31, 2026
First Submitted That Met QC Criteria
April 7, 2026
First Posted (Actual)
April 9, 2026
Study Record Updates
Last Update Posted (Actual)
April 9, 2026
Last Update Submitted That Met QC Criteria
April 7, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3D-printed (PEEK)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data (IPD) will not be shared due to privacy and confidentiality considerations.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fracture Mandible
-
AO Clinical Investigation and Publishing DocumentationAOCMFCompletedBilateral Condylar Fracture of the MandibleUnited States, Taiwan, Switzerland, South Africa, Finland, Slovenia, Pakistan, Spain, Germany, Malaysia, Mexico, Netherlands, Ukraine, Uruguay
-
Oxford University Hospitals NHS TrustCompletedCondylar Process of Mandible Open FractureUnited Kingdom
-
Dow University of Health SciencesRecruitingTo Assess the Bone Healing in Fracture Mandible DefectsPakistan
-
Stryker CraniomaxillofacialCompletedMandible; Deformity | Mandible Fracture | Mandibular Fractures | MANDIBLE | Orthognathic Surgical ProceduresUnited States
-
Hennepin Healthcare Research InstituteUniversity of Minnesota; Regions HospitalCompletedSmoking | Inflammation | Surgery | Surgery--Complications | Wound Infection | Oxidative Stress | Wound | Mandible Fracture | Mandibular Fractures | Vitamin C Deficiency | Ascorbic Acid Deficiency | Wound Complication | Wound of Skin | Wound Dehiscence | Mandible Open Fracture | Mandible Closed FractureUnited States
-
Alexandria UniversityCompletedMandible Fracture | Mandibular Fracture TraumaEgypt
-
Sohag UniversityActive, not recruitingMaxillofacial Injuries | Maxillofacial Trauma | Subcondylar Process of Mandible Closed Fracture | Orbital Floor (Blow-Out) Closed Fracture | Frontal Sinus FractureEgypt
-
Alexandria UniversityRecruitingMandible FractureEgypt
-
Cairo UniversityUnknownMandibular Fractures | Fracture MandibleEgypt
-
Cairo UniversityNot yet recruiting